share_log

Iris Energy | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

SEC announcement ·  Mar 21 08:26
Summary by Moomoo AI
Iris Energy Limited, known as IREN in the United States, has expanded its At Market Issuance Sales Agreement by adding three new sales agents: Canaccord Genuity LLC, Citigroup Global Markets Inc., and Macquarie Capital (USA) Inc. This amendment took place on March 21, 2024. Concurrently, the company filed a new prospectus supplement, increasing the aggregate offering price of its ordinary shares by $200 million, bringing the total to $500 million. As of March 15, 2024, Iris Energy has sold ordinary shares amounting to $261,471,363 under the Sales Agreement. The ordinary shares are registered under the company's shelf registration statement on Form F-3, and sales are made through prospectus supplements. This report, filed on March 21, 2024, is incorporated by reference into Iris Energy's existing registration statements and is accompanied by a legal opinion from Clifford Chance LLP.
Iris Energy Limited, known as IREN in the United States, has expanded its At Market Issuance Sales Agreement by adding three new sales agents: Canaccord Genuity LLC, Citigroup Global Markets Inc., and Macquarie Capital (USA) Inc. This amendment took place on March 21, 2024. Concurrently, the company filed a new prospectus supplement, increasing the aggregate offering price of its ordinary shares by $200 million, bringing the total to $500 million. As of March 15, 2024, Iris Energy has sold ordinary shares amounting to $261,471,363 under the Sales Agreement. The ordinary shares are registered under the company's shelf registration statement on Form F-3, and sales are made through prospectus supplements. This report, filed on March 21, 2024, is incorporated by reference into Iris Energy's existing registration statements and is accompanied by a legal opinion from Clifford Chance LLP.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more